Geert Kleinnibbelink

Chapter 8 182 REFERENCES 1. Gall H, Felix JF, Schneck FK, Milger K, Sommer N, Voswinckel R, Franco OH, Hofman A, Schermuly RT, Weissmann N, Grimminger F, Seeger W and Ghofrani HA. The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups. J Heart Lung Transplant . 2017;36:957-967. 2. Voelkel NF, Quaife RA, Leinwand LA, Barst RJ, McGoon MD, Meldrum DR, Dupuis J, Long CS, Rubin LJ, Smart FW, Suzuki YJ, Gladwin M, Denholm EM, Gail DB, National Heart L, Blood Institute Working Group on C and Molecular Mechanisms of Right Heart F. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation . 2006;114:1883-91. 3. Simonneau G, Torbicki A, Hoeper MM, Delcroix M, Karlocai K, Galie N, Degano B, Bonderman D, KurzynaM, EfficaceM, Giorgino R and Lang IM. Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension. Eur Respir J . 2012;40:874-80. 4. Sitbon O, Channick R, Chin KM, Frey A, Gaine S, Galie N, Ghofrani HA, Hoeper MM, Lang IM, Preiss R, Rubin LJ, Di Scala L, Tapson V, Adzerikho I, Liu J, Moiseeva O, Zeng X, Simonneau G, McLaughlin VV and Investigators G. Selexipag for the Treatment of Pulmonary Arterial Hypertension. N Engl J Med . 2015;373:2522-33. 5. Hulshof HG, Eijsvogels TMH, Kleinnibbelink G, van Dijk AP, George KP, Oxborough DL and Thijssen DHJ. Prognostic value of right ventricular longitudinal strain in patients with pulmonary hypertension: a systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging . 2019;20:475-484. 6. Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk NoordegraafA, BeghettiM, Ghofrani A, GomezSanchezMA,HansmannG, KlepetkoW, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M and Group ESCSD. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis andTreatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J . 2016;37:67-119. 7. Oxborough D, Heemels A, Somauroo J, McClean G, Mistry P, Lord R, Utomi V, Jones N, Thijssen D, Sharma S, Osborne R, Sculthorpe N and George K. Left and right ventricular longitudinal strain-volume/area relationships in elite athletes. Int J Cardiovasc Imaging . 2016;32:1199-211. 8. Hulshof HG, van Dijk AP, George KP, Merkus D, Stam K, van Duin RW, van Tertholen K, Hopman MTE, Haddad F, Thijssen DHJ and Oxborough DL. Echocardiographic-Derived Strain-Area Loop of the Right Ventricle is Related to Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension. JACC Cardiovasc Imaging . 2017;10:1286-1288. 9. Kleinnibbelink G, Hulshof HG, van Dijk APJ, Cate TT, George KP, Oxborough DL and Thijssen DHJ. Effects of preload manipulation on right ventricular contractility: invasive pressure-area loop versus non-invasive strain-area loop. J Am Soc Echocardiogr . 2020. 10. Hulshof HG, van Dijk AP, Hopman MTE, Heesakkers H, George KP, Oxborough DL and Thijssen DHJ. 5-Year prognostic value of the right ventricular strain-area loop in patients with pulmonary hypertension. Eur Heart J Cardiovasc Imaging . 2020.